Nick Dand

Clinical and genetic differences between pustular psoriasis subtypes

Sophie Twelves, Alshimaa Mostafa, Nick Dand et al. · Journal of Allergy and Clinical Immunology · 2018 · 268 citations · Full text

Life Sciences, Dermatology, Genetics +15

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

Nick Dand, Michael Duckworth, David Baudry et al. · Journal of Allergy and Clinical Immunology · 2018 · 174 citations · Full text

Life Sciences, Genetics, Immunology +14

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

Satveer K. Mahil, Nick Dand, K.J. Mason et al. · Journal of Allergy and Clinical Immunology · 2020 · 160 citations · Full text

Medicine, Dermatology, Health Sciences +12

Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, <scp>BADBIR</scp> )

Nina Wilson, Nick Dand, Nick J. Reynolds et al. · British Journal of Dermatology · 2019 · 154 citations · Full text

Medicine, Clinical Sciences, Dermatology +13

An analysis of IL-36 signature genes and individuals with <i>IL1RL2</i> knockout mutations validates IL-36 as a psoriasis therapeutic target

Satveer K. Mahil, Marika Catapano, Paola Di Meglio et al. · Science Translational Medicine · 2017 · 149 citations · Full text

Life Sciences, Dermatology, Immunology +17